O

OBIO

Orchestra BioMed Holdings Inc

2.65

-0.22-7.67%
After Hours: 2.800  +0.150  +5.66%17:36 05/09 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-50.56M

-46.13M

-29.29M

-19.43M

-26.18M

Net Income

-61.02M

-49.12M

-33.61M

-23.01M

-21.36M

Depreciation/Depletion & Amortization

308.00K

287.00K

222.00K

181.00K

137.00K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

10.92M

6.01M

4.55M

774.00K

3.22M

Changes in Working Capital

-765.00K

-3.31M

-451.00K

2.63M

-8.19M

Cash from Investing Activities

13.09M

10.69M

-64.12M

13.02M

26.97M

Capital Expenditures

-891.00K

-78.00K

-591.00K

-274.00K

-539.00K

Other Investing Cash Flow Items, Total

13.98M

10.77M

-63.53M

13.29M

27.50M

Cash from Financing Activities

29.17M

46.22M

103.26M

-3.99M

10.00M

Financing Cash Flow Items

-1.10M

56.81M

-10.32M

0

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

15.28M

254.00K

110.02M

7.00K

0

Issuance (Retirement) of Debt, Net

15.00M

-10.85M

3.55M

-4.00M

10.00M

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

-8.30M

10.78M

9.85M

-10.40M

10.78M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

--

--

--

--

--